These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3972656)
21. Percutaneous ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent head and neck carcimonas. Jiang P; Jiang Y; Wang JJ; Meng N; Ran W; Qu A; Yang R Cancer Biother Radiopharm; 2011 Dec; 26(6):753-7. PubMed ID: 22133099 [TBL] [Abstract][Full Text] [Related]
22. Interstitial iodine 125 in advanced recurrent squamous cell carcinoma of the head and neck with follow-up evaluation of carotid artery by ultrasound. Chen KY; Mohr RM; Silverman CL Ann Otol Rhinol Laryngol; 1996 Dec; 105(12):955-61. PubMed ID: 8973282 [TBL] [Abstract][Full Text] [Related]
23. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Nag S; Cano ER; Demanes DJ; Puthawala AA; Vikram B; Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1190-8. PubMed ID: 11483328 [TBL] [Abstract][Full Text] [Related]
24. Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck. Park RI; Liberman FZ; Lee DJ; Goldsmith MM; Price JC Laryngoscope; 1991 Apr; 101(4 Pt 1):405-10. PubMed ID: 1895857 [TBL] [Abstract][Full Text] [Related]
25. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Beitler JJ; Smith RV; Silver CE; Quish A; Deore SM; Mullokandov E; Fontenla DP; Wadler S; Hayes MK; Vikram B Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):313-7. PubMed ID: 9457815 [TBL] [Abstract][Full Text] [Related]
26. Clinical effectiveness of 125I-seed implantation in combination with nimotuzumab therapy for the advanced oral carcinoma: preliminary results. Meng J; Wang X; Zhuang QW; Gu QP; Zhang J; Li ZP Eur Rev Med Pharmacol Sci; 2014; 18(21):3304-10. PubMed ID: 25487943 [TBL] [Abstract][Full Text] [Related]
27. 125Iodine brachytherapy for colorectal adenocarcinoma recurrent in the pelvis and paraortics. MartÃnez-Monge R; Nag S; Martin EW Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):545-50. PubMed ID: 9806513 [TBL] [Abstract][Full Text] [Related]
28. [Ultrasound guided implantation of radioactive (125)I seeds for treatment of recurrent head and neck carcinomas]. Jiang P; Ma Y; Wang JJ; Ran WQ; Jiang YL; Qu A Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):291-4. PubMed ID: 22517006 [TBL] [Abstract][Full Text] [Related]
30. Postoperative 125I brachytherapy delivered by digital model obturators for recurrent or locally advanced maxillary cancers. Huang MW; Zhang JG; Tong D; Zhang J; Zheng L; Zhang Y; Yu GY Laryngoscope; 2012 Nov; 122(11):2461-7. PubMed ID: 22965822 [TBL] [Abstract][Full Text] [Related]
31. Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032. Smith RP; Schuchert M; Komanduri K; Burton S; Heron DE; Luketich JD; d'Amato T; Landreneau R Ann Surg Oncol; 2007 Dec; 14(12):3610-3. PubMed ID: 17909906 [TBL] [Abstract][Full Text] [Related]
32. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Chen A; Galloway M; Landreneau R; d'Amato T; Colonias A; Karlovits S; Quinn A; Santucci T; Kalnicki S; Brown D Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1057-63. PubMed ID: 10421539 [TBL] [Abstract][Full Text] [Related]
33. Clinical application of computed tomography-guided (125)I seed interstitial implantation for head and neck cancer patients with unmanageable cervical lymph node metastases. Huang H; Xu S; Li F; Du Z; Wang L Eur J Med Res; 2016 Apr; 21():18. PubMed ID: 27121405 [TBL] [Abstract][Full Text] [Related]
35. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck. Wiegand S; Sesterhenn AM; Zimmermann AP; Strassmann G; Wilhelm T; Werner JA Anticancer Res; 2013 Jan; 33(1):249-52. PubMed ID: 23267152 [TBL] [Abstract][Full Text] [Related]
37. [Brachy-curietherapy using iodine-125 in the treatment of recurrences of cervicofacial tumors. Our results]. Strohm M; Sturm V; Ahlemann LM; Eitel M; Pleininger M; Schrader M Rev Laryngol Otol Rhinol (Bord); 1988; 109(1):5-7. PubMed ID: 3375623 [No Abstract] [Full Text] [Related]
38. Intraoperative radiotherapy in patients with recurrent head and neck cancer. Vikram B; Strong EW; Shah JP; Spiro RH; Gerold F; Sessions RB; Hilaris BS Am J Surg; 1985 Oct; 150(4):485-7. PubMed ID: 4051112 [TBL] [Abstract][Full Text] [Related]
39. Retreatment of recurrent carcinoma of the head and neck by afterloading interstitial 192Ir implant. Emami B; Marks JE Laryngoscope; 1983 Oct; 93(10):1345-7. PubMed ID: 6621236 [TBL] [Abstract][Full Text] [Related]
40. Clinical application and accuracy assessment of imaging-based surgical navigation guided 125I interstitial brachytherapy in deep head and neck regions. Zhang G; Wu Z; Yu W; Lyu X; Wu W; Fan Y; Wang Y; Zheng L; Huang M; Zhang Y; Guo C; Zhang J J Radiat Res; 2022 Sep; 63(5):741-748. PubMed ID: 35818292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]